Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.1500 (-0.49%) ($9.1500 - $9.1500) on Mon. Jan. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.83% (three month average) | RSI | 85 | Latest Price | $9.1500(-0.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 10.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.415% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.415% (StdDev 4.83%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $9.15(0%) | 10 Day Moving Average | $8.71(5.05%) | 20 Day Moving Average | $8.1(12.96%) | To recent high | -1% | To recent low | 81.7% | Market Cap | $1.614b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |